Jo u r n a l o f C linical M ic r o b io l o g y , Dec. 1995; p. 3150-3153 0095-1137/95/$04.00+0 The performance of a sandwich enzyme-linked immunosorbent assay (ELISA) which detects Aspergillus galactomannan (GM) was evaluated in bronchoalveolar lavage (BAL) fluid samples from 19 patients who were treated for hematological malignancies and who were suspected of having invasive pulmonary aspergillosis (IPA), All patients had fever and pulmonary infiltrates on the chest roentgenogram on the day that the BAL fluid was obtained. The ELISA results were compared with the results of culture and Aspergillus genus-specific PCR analysis of BAL fluid samples. ELISA was also performed with serum samples. Aspergillus species were detected by PCR or ELISA with BAL fluid samples from five of seven patients who had radiological evidence of IPA. Serum ELISA results were positive for all patients with ELISA-positive BAL fluid, and for four patients the serum ELISA was positive before the BAL fluid was obtained. PCR and ELISA were positive for 2 and I of 10 BAL fluid samples, respectively, obtained from patients without radiological evidence of IPA, and 5 and 2 of 35 BAL fluid samples, respectively, obtained from nonneutropenic patients. This preliminary investigation suggests that GM may be detected by ELISA in BAL fluid samples from patients at risk of IPA, but that monitoring of serum GM levels may allow for the earlier diagnosis of IPA. However, further evaluation in prospective studies is required.
Invasive pulmonary aspergillosis (IPA) is a major threat to leukemic patients with cytotoxic therapy-induced neutropenia and transplant recipients receiving high-dose corticosteroid therapy. Since the diagnosis of IPA in an early stage is seldom possible and the mortality rate is very high (6) , successful treatment is directly related to early diagnosis (1), Several methods for obtaining an early and rapid diagnosis of IPA are now under study. Aspergillus DNA can be detected in bron choalveolar lavage (BAL) fluid by PCR (5, 16, 18, 22, 25) , but the numbers of patients and controls tested have been too limited to establish the diagnostic value of this technique. An alternative approach is to detect circulating Aspergillus antigen in body fluids, e.g., serum or urine, by a number of in-house methods (12, 19, 20) . The Aspergillus antigen test (Pastorex Aspergillus^ Sanofì Diagnostics Pasteur, Marnes-la-Coquette, France) is commercially available and uses the rat monoclonal antibody EB-A2 to detect galactomannan (GM), a polysaccha ride antigen of Aspergillus species (13) . This antigen test has been evaluated in several institutes (4, 8, 9, 26, 29) , but it has been found to lack sufficient sensitivity (8, 9, 26, 29) . A recent ly developed sandwich enzyme-linked immunosorbent assay (ELISA) allowed the detection of low levels of circulating Aspergillus GM in sera from patients at high risk of IPA, but the increase in sensitivity was also associated with false-positive results in up to 8% of the serum samples (21, 27) . Since IPA is predominantly a pulmonary infection in immunocompromised patients, and Aspergillus fumiga tus is known to release GM into the culture medium when it is grown in vitro (13) , detectable antigen levels may be present in BAL fluid samples from pa tients suspected of having IPA and therefore may be of use for the diagnosis of' IPA.
We therefore investigated the use of the sandwich ELISA to detect GM with BAL fluid samples which had been collected from patients at high risk and from patients at low risk of IPA, The results were compared with those obtained by culture and 
MATERIALS AND METHODS
Patients. During a '12-month period 19 consecutive BAL fluid samples had been collected from patients who were neutropenic as a result of cytotoxic therapy or from whom circulating granulocytes were recovered. In each patient a bronchoscopy was performed because fever (temperature, >38.3°C) persisted despite treatment with broad-spectrum antibacterial agents and pulmonary in filtrates developed on the chest roentgenogram. The BAL Huid sample was obtained by wedging a flexible bronchoscope in the area of maximal roeutgenographic involvement, after which 150 ml of sterile 0.9% saline was instilled and approximately 100 ml was recovered by suclioning. The medical, histopalhological, microbiological, and radiological records of all patients were reviewed for evidence of IPA or other respiratory disease. Since a definitive diagnosis of IPA is very difficult to establish in this patient group, the patients were allocated to three categories by review of the appearance oí the pulmonary infiltrates on the chest roentgenogram by two physicians who were blinded to the medical histories of the patients. The patients were allocated to one of the following groups: A, probable IPA (n = 7), with the chest roentgenogram showing focal nonanatomical infiltrates or any cavitating lesion; C> unlikely IPA (n -10), with the chest roentgenogram showing diffuse infiltrates characterized by nodular, reticular, or reticulonodular lesions which were distributed throughout both lung fields or anatomical focal infiltrates (15) ; and B, possible IPA (n = 2), which included Vol. 33, 1995 ASPERGILL US ANTIGEN DETECTION AND PCR OF BAL FLUID 3151 patients with infiltrates on the chest roentgenogram who could not be classified intu group A or C. Of course, the reliability of these definitions is limited because the roentgenographic pattern is not always specific for the infectious etiology of the infiltrates. Furthermore, 35 BAL Huid samples were collected 1'rom nonneutropenic patients who were at low risk for IPA.
Sample collection. BAL fluid samples were routinely examined for the pres ence of bacteria, viruses, fungi, and parasites, A total of 5 to 1(1 ml of each sample was stored at -8U°C until analysis by ELISA and PCR. The microbiological records were reviewed for serum samples winch had been collected from each patient between 6 weeks before and 2 weeks after the BAL Huid sample was obtained. These samples had also been stored at -80°C until testing by ELISA was performed.
Aspergillus culture. Routine culture for fungi was performed after centrifuga tion of the BAL fluid sample at 1,500 x g for 10 min. The pellet was plated onto Sabouraud glucose (2%) agar and was cultured for 5 days at 28 and 48Ü C. Aspergillus species were identified by one technician (AJ.M.VLR.) by their cul tural characteristics and the morphologies of their conidiophores and conidia.
PCR amplification. After thawing, the BAL fluid samples were centrifuged at 1,500 X g for 1(1 min. The supernatant was separated from the pellet, leaving a residue of 0.5 ml in which the pellet was resuspended. PCR analysis was per formed as described previously (16, 25) . Briefly, high-frequency shaking was performed to achieve complete cell destruction; this was followed by purification of nucleic acids by guanidium thiocyanate-containing lysis buffer and silica par ticles. A hot-start PCR was performed with two Aspergillus genus-specific prim ers. This PCR assay can detect a wide range of the Aspergillus species involved in human disease specifically when it is combined with Southern blot hybridization and restriction enzyme analysis (16) .
ELISA. The sandwich ELISA used to delect Aspcjgillw GM in serum samples and BAL fluid supernatants was performed exactly as described previously (21) . Saline (0.9%) and culture-and PCR-negative BAL fluid supernatants from patients at low risk of IPA containing a range of dilutions of GM (range, 0.25 to 10 ng/ml) and a negative control BAL fluid sample were included in each test. All serum and BAL fluid samples were tested in duplicate by one technician who was unaware of the clinical data. The microtiter plates were prepared by the manu facturer (Sanofi Pasteur Diagnostics), and the coating conditions of the plates are proprietary. However, since the coating conditions of the EB-A2 monoclonal antibody on the microtiter plate were different from those reported previously (21) , lower optical density values were found. Table 2 . Five of seven BAL fluid samples from patients with probable IPA were positive by PCR and ELISA. GM was detected in serum samples from all pa tients with an ELISA-posilive BAL fluid sample. Moreover, serum samples were available from the period before the bron choscopy was performed for four patients, and GM could be detected up to 30 days before the BAL fluid sample was ob tained (patient A5; Table 2 ). Shortly after bone marrow trans plantation during severe neutropenia, patient A5 developed fever and sinusitis. The administration of ciprofloxacin and amoxicillin-clavulanic acid did not result in clinical improve ment, and amphotericin B (1 mg/kg of body weight per day) was added to the regimen. During recovery of the granulo cytes, a chest roentgenogram showed the development of a nodular infiltrate. Although culture of sinus aspirate and BAL fluid remained negative, PCR and ELISA of BAL fluid sam ples were positive, and GM was retrospectively detected in the serum at the time that the sinusitis first became apparent.
Both PCR and ELISA were positive for one of two BAL fluid samples from patients with possible IPA, but serum sam ples were not available for analysis by the ELISA. The PCR was positive for BAL fluid samples from patients C l and C2, who had no evidence of the presence of IPA, and GM was not detected in the BAL fluid or serum samples from these pa tients. GM was detected in a PCR-negative BAL fluid sample from patient C3, and two of seven serum samples were also found to be positive. The two ELISA-positive serum samples were obtained on the day that the BAL was performed and 1 day thereafter, respectively. Five consecutive serum samples obtained during 2 weeks following the BAL were all negative, even though severe neutropenia persisted and at the time of the seroconversion only a loading dose of 10 mg of amphoter icin B had been administered. Treatment with ciprofloxacin and amphotericin B (1 mg/kg/d ay) for 2 weeks resulted in resolution of the pulmonary infiltrates.
Nonneutropenic patients. PCR analysis of 35 BAL fluid samples from nonneutropenic patients revealed positive am plification reactions for five samples which were all negative by ELISA (25) . The ELISA was positive for 2 of 30 PCR-negative BAL fluid samples (Table 1) .
DISCUSSION
The diagnosis of IPA in an early stage of the disease is of great importance since early antifungal treatment is associated with an improved outcome (1). The early diagnosis of IPA is difficult, and a definitive diagnosis is often made at autopsy. The presence of severe thrombocytopenia in neutropenic pa tients limits the use of invasive diagnostic procedures to obtain a specimen for culture and histopathological examination. BAL has been advocated as a safe procedure for obtaining a specimen for the diagnosis of IPA in immunocompromised patients with pulmonary infiltrates. Although the recovery of Aspergillus species from BAL fluid is highly indicative of IPA, the diagnostic yield from culture of BAL fluid samples is only 30% (24) . Therefore, attention has focused on other tech niques for the early diagnosis of IPA, such as Aspergillusspecific PCR of BAL fluid (5, 16, 18, 22) and the detection of circulating Aspergillus antigen in serum or urine (4, 8, 9, 12, 19-21, 26, 29) . Little is known about the utility of Aspergillus antigen detection in BAL fluid. One research group has pre 3152 VERWEIJ ET AL. viously described the use of a radioimmunoassay to detect an uncharacterized purified A. fumigatus carbohydrate in BAL fluid (2, 3, 30) . This radioimmunoassay detected Aspergillus antigen in 91% of the BAL fluid samples from rabbits with IPA, and in 21% of these animals antigen was detected in BAL fluid only and not in serum (2) . The radioimmunoassay was also used to detect Aspergillus antigen in BAL fluid samples from nine immunocompromised patients with pulmonary in filtrates, and two patients were found to be positive (3) . GM was detected by a latex agglutination test (Pastortx Aspergillus) in BAL fluid samples from three patients with AIDS and IPA (14) . However, GM could not be detected by the same test under laboratory conditions in BAL fluid samples from 14 untreated rabbits with IPA, while serum samples from 10 (71%) animals were positive (7) . Although the present study was limited by the difficulty in reliably classifying patients with IPA, GM was detected by sandwich ELISA in BAL fluid sam ples from five of seven patients with radiological evidence of IPA, and therefore, this test may be promising for use in the diagnosis of this infection.
The increase in the level of sensitivity required to diagnose early IPA, however, is hampered by an increase in the number of false-positive results. For this reason, it was interesting to compare DNA and GM detection, since these two assays have a different target. In the case of diagnosis by PCR, a positive result obtained from the use of a BAL fluid sample can be due to the presence of contaminating conidia without any mycelial development (see, for example, data for patients Cl and C2). Indeed, previous studies found a rate of 15% positive PCR amplification in BAL fluid samples from nonneutropenic pa tients (22, 25) . The occurrence of a negative PCR result for patient A6, whose BAL fluid and serum samples were GM positive and who had radiological and clinical evidence of IPA, could be due to the presence of inhibitors of the PCR in the BAL fluid (23) .
False-positive results were also obtained by the sandwich ELISA. The reasons for the false-positive reactions are un known, but it has been shown that molecules which are respon sible for the false positivity appear to mimic the epitope rec ognized by anti-GM monoclonal antibodies (21) . In 30 cultureand PCR-negative BAL fluid' samples from nonneutropenic patients, a 7% false-positive rate was found, which is similar to the 8% false-positive rate found in serum (21) . A 10-fold con centration of the samples by acetone precipitation resulted in a false-positive rate of 27% (data not shown). Analysis by PCR and ELISA can be done in less than 24 h (PCR, 24 h; ELISA, 4 h), and the results can be forwarded to the clinician on the day following the BAL.
An excellent correlation was found between serum and BAL fluid ELISA results, and GM was detected in the serum even V ol. 33, 1995 ASPERGILLUS ANTIGEN DETECTION AND PCR OF BAL FLUID 3153 before the BAL was performed. Since a bronchoscopy was performed only after pulmonary infiltrates were present on the chest roentgenogram, GM may be detectable in the serum before infiltrates become visible on the plain chest film. It has been shown that in neutropenic patients abnormalities are difficult to detect on plain chest film (17) and that other radio logic methods, such as high-resolution computed tomography, are more sensitive for the detection of pulmonary infiltrates in these patients (1.0, 1 1 , 28) and may even be used for therapeu tic monitoring (28) .
This preliminary investigation suggests that both Aspergillus genus-specific PCR and sandwich ELISA might be beneficial for use in the early diagnosis of IPA in patients with hemato logical malignancies. The ELISA is relatively easy to perform, and the results are available within 4 h. Since false-positive results may be found by ELISA of the serum, detection of Aspergillus species in BAL fluid by ELISA or PCR may provide additional evidence for the presence of IPA. The results of the present study also suggest that in some patients GM antigenemia may be detected in serum before pulmonary infiltrates are visible on the chest roentgenogram. However, carefully designed prospective studies need to be performed in order to evaluate the diagnostic value of these assays. We are prospeclively monitoring serum GM levels by ELISA in patients dur ing cytotoxic therapy-induced neutropenia. When GM is de tected for the first time, confirmation is sought by ELISA with additional serum samples, high-resolution computed tomogra phy scan, and where possible, bronchoscopy and PCR analysis of BAL fluid. Once the presence of GM is confirmed or the signs or symptoms pathognomonic for IPA have developed, treatment with antifungal agents is started preemptively. By following these guidelines, the diagnosis and treatment of IPA may be possible at an early stage of infection.
